1. Home
  2. XLO vs LFVN Comparison

XLO vs LFVN Comparison

Compare XLO & LFVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

XLO

Xilio Therapeutics Inc.

HOLD

Current Price

$7.79

Market Cap

49.8M

Sector

Health Care

ML Signal

HOLD

Logo Lifevantage Corporation (Delaware)

LFVN

Lifevantage Corporation (Delaware)

HOLD

Current Price

$9.65

Market Cap

51.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
XLO
LFVN
Founded
2016
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
49.8M
51.5M
IPO Year
2021
1996

Fundamental Metrics

Financial Performance
Metric
XLO
LFVN
Price
$7.79
$9.65
Analyst Decision
Buy
Strong Buy
Analyst Count
1
1
Target Price
$28.00
$11.00
AVG Volume (30 Days)
29.0K
616.5K
Earning Date
05-14-2026
05-06-2026
Dividend Yield
N/A
3.56%
EPS Growth
N/A
226.09
EPS
N/A
0.30
Revenue
$43,766,000.00
$203,204,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$168.77
N/A
P/E Ratio
N/A
$34.97
Revenue Growth
589.88
1.86
52 Week Low
$0.46
$3.90
52 Week High
$9.25
$15.00

Technical Indicators

Market Signals
Indicator
XLO
LFVN
Relative Strength Index (RSI) 42.24 68.50
Support Level $7.40 $4.86
Resistance Level $8.97 $11.71
Average True Range (ATR) 0.40 1.54
MACD -0.11 0.30
Stochastic Oscillator 13.11 69.63

Price Performance

Historical Comparison
XLO
LFVN

About XLO Xilio Therapeutics Inc.

Xilio Therapeutics Inc is a clinical-stage biotechnology company focused on discovering and developing masked immuno-oncology (I-O) therapies to improve outcomes for people living with cancer. Leveraging its clinically validated masking technology and capabilities, the company develops I-O therapies designed to selectively activate within the tumor microenvironment to achieve durable efficacy without the severe side effects associated with systemically active I-O agents. Its integrated biology and protein engineering approach enables the design and development of potent masked biologics that are activated by tumor-specific proteases.

About LFVN Lifevantage Corporation (Delaware)

Lifevantage Corp is engaged in the identification, research, development, and distribution of nutraceutical dietary supplements and skincare products. It offers products such as Protandim, a scientifically-validated dietary supplement; LifeVantage TrueScience, an anti-aging skincare product; Axio energy drink mixes; and PhysIQ, a weight management system and other product Geographically, its products are sold in the regions of the United States, Japan, Hong Kong, Australia, Canada, Philippines, Mexico, Thailand, the United Kingdom, and the Netherlands.

Share on Social Networks: